39 results
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
5 Apr 24
Regulation FD Disclosure
11:26am
(“PPARs”) are also considered potential therapeutic targets for neurodegenerative disorders such as AD. PPAR’s are ligand-activated transcription
8-K
EX-99.1
4j35mey b3zne
24 Oct 23
Regulation FD Disclosure
4:18pm
8-K
EX-99.1
2o3bpr0ty q9qd0k
1 Jun 23
InMed’s Neurodegenerative Disease Study Presented at Canadian Neuroscience Meeting
1:27pm
424B5
4fn9 gqnns37jhudh
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
dkgeu
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
08xdlsvbk40f0om
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
50xwqm43kzv9g yywek
7 Apr 22
Prospectus supplement
4:46pm